LeafNLP Demos
Back to explore

Report #2888094

Received Mar 9, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
74 yrs
State
RI
Recovered
Unknown
Vaccinated
Mar 2, 2026
Onset
Mar 1, 2026
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2UNK—

Symptoms (4)

AstheniaChillsDizzinessVomiting

Symptom narrative

Vomiting; Weakness; Dizziness; Chills; This non-serious case was reported by a consumer via call center representative and described the occurrence of vomiting in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose of Shingrix on an unknown date). On 02-MAR-2026, the patient received the 2nd dose of Shingrix. In MAR-2026, less than a week after receiving Shingrix, the patient experienced vomiting (Verbatim: Vomiting), weakness (Verbatim: Weakness), dizziness (Verbatim: Dizziness) and chills (Verbatim: Chills). The outcome of the vomiting, weakness, dizziness and chills were unknown. It was unknown if the reporter considered the vomiting, weakness, dizziness and chills to be related to Shingrix. It was unknown if the company considered the vomiting, weakness, dizziness and chills to be related to Shingrix. Additional Information: GSK Receipt Date: 03-MAR-2026 The batch number was not provided and request for this information has been made.